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Structural Basis for the Dual Thymidine
and Thymidylate Kinase Activity
of Herpes Thymidine Kinases
1979; Elion et al., 1977). This wide substrate specificity
gives these kinases their medicinal relevance.
The best studied anticancer gene therapy strategy is
the HSV1-TK/ganciclovir system. Suicide gene therapy
of cancers and graft-versus-host disease (GVHD) pre-
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a prodrug by an exogenously introduced enzyme. In thisChicago, Illinois 60612
2 Max Planck Institute for Biophysical Chemistry system, the HSV1-TK enzyme renders mammalian cells
sensitive to ganciclovir (GCV). GCV is phosphorylatedDepartment of Molecular Genetics
37070 Go¨ttingen by HSV1-TK to GCV-monophosphate (GCV-MP) and
subsequently to GCV-diphosphate (GCV-DP) (MatthewsGermany
and Boehme, 1988) and cytotoxic GCV-triphosphate
(GCV-TP) by cellular enzymes (Reardon, 1989; St. Clair
et al., 1987). Improving such therapies, then, dependsSummary
on improving the prodrug, the enzyme, or the method
of delivery of either the prodrug or the enzyme.Crystal structures of equine herpesvirus type-4 thymi-
dine kinase (EHV4-TK) in complex with (i) thymidine
and ADP, (ii) thymidine and SO4 and the bisubstrate
analogs, (iii) TP4A, and (iv) TP5A have been solved.
Additionally, the structure of herpes simplex virus
type-1 thymidine kinase (HSV1-TK) in complex with
TP5A has been determined. These are the first struc-
tures of nucleoside kinases revealing conformational
Scheme 2.transitions upon binding of bisubstrate analogs. The
structural basis for the dual thymidine and thymidylate Human nucleoside kinases activate GCV much less
kinase activity of these TKs is elucidated. While the efficiently than does HSV1-TK, so GCV’s toxicity toward
active sites of HSV1-TK and EHV4-TK resemble one non-HSV1-TK-transduced cells is extremely low. EHV4-
another, notable differences are observed in the Lid TK is 36% identical to HSV1-TK, and a study on human
regions and in the way the enzymes bind the base of and murine cell lines demonstrated the superiority of
the phosphoryl-acceptor. The latter difference could EHV4-TK over HSV1-TK at activation of GCV (Loubiere
partly explain the higher activity of EHV4-TK toward et al., 1999).
the prodrug ganciclovir. We wish to understand EHV4-TK’s superiority over
HSV1-TK at phosphorylating GCV. We also strive to un-
Introduction derstand the dual thymidine and thymidylate kinase ac-
tivity of EHV4-TK (Thy to TMP, TMP to TDP) and how it
Herpes simplex virus type-1 thymidine kinase (HSV1-TK) compares to that of HSV1-TK; such dual activity is ab-
and equine herpesvirus type-4 thymidine kinase (EHV4- sent in other known nucleoside kinases. The Michaelis
TK) catalyze the reversible phosphorylation of thymidine complex of the thymidine kinase reaction has three
(Thy) to thymidine monophosphate (TMP) as well as that phosphate groups—either all from ATP or two from ADP
of TMP to thymidine diphosphate (TDP), using ATP as and one from TMP, depending on the reaction direction.
a phosphoryl donor according to the following reaction In contrast, the thymidylate kinase complex has four
scheme (Chen and Prusoff, 1978; Chen et al., 1979): phosphate groups bound to the active site—three from
ATP and one from TMP, or two each from ADP and
TDP. An hypothesis for HSV1-TK’s dual activity has been
offered (Wild et al., 1997), but known HSV1-TK structures
do not give information on the four-phosphate confor-
mation of the enzyme (Bennett et al., 1999; Champness
et al., 1998; Prota et al., 2000; Vogt et al., 2000; Wild et al.,
1997). We would also like to understand the structural
Scheme 1. features of the viral TKs that enable dual activity toward
Thy but not toward medicinal compounds.
In addition to this physiological dual thymidine kinase The questions we pose are as follows: how does the
and thymidylate kinase activity, the herpes thymidine same enzyme accommodate substrates of different size
kinases can phosphorylate pyrimidine nucleosides, py- and charge (i.e., Thy or TMP)? For example, do the catalytic
rimidine nucleoside monophosphates, and several nu- residues change conformation when interacting with
cleoside analogs (Chen and Prusoff, 1978; Chen et al., Thy versus TMP? Or does the donor nucleotide and/or
the acceptor nucleoside/nucleotide occupy a different
position in the active site? To address these questions,*Correspondence: lavie@uic.edu
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Table 1. Data Collection and Refinement Statistics
EHV4-TK  SO4-Thy EHV4-TK  ADP-Thy EHV4-TK  TP4A EHV4-TK  TP5A HSV1-TK  TP5A
PDB deposition code 1P6X 1P72 1P73 1P75 1P7C
Data Collection Statistics
Space group C2221 C2221 P21212 P21212 C2221
Unit cell (A˚)
a 111.65 112.30 111.35 106.80 113.22
b 121.55 121.01 118.29 117.20 117.85
c 118.83 118.81 122.65 124.94 108.40
Resolution 2.0 2.0 2.7 3.0 2.1
Observed reflections 423469 242846 902706 613603 198478
Unique reflections 54599 47461 45176 31559 41672
Completeness (%)
Overall/last shell 99.6/99.8 96.8/96.9 98.4/91.0 96.8/88.9 97.9/97.9
I/sigma(I)
Overall/last shell 13.12/2.72 18.2/2.7 14.6/2.9 12.8/5.1 13.2/3.9
Rsym (%)
Overall/last shell 9.6/46.4 6.2/32.1 9.7/37.8 11.8/26.5 7.2/31.9
Molecules/asymmetric unit 2 2 4 4 2
Refinement Statistics
Resolution range (A˚) 30–2.0 25–2.1 30–2.7 30–3.02 35.9–2.1
Reflections with F  0
Working 49207 41415 40082 27616 37137
Test 5392 4541 4439 2988 4142
Rcryst (%) 18.7 18.4 21.3 20.2 23.9
Rfree (%) 23.7 23.2 27.6 29.8 28.5
Number of:
Protein atoms 5213 5112 9788 10157 4655
Nucleotide atoms 44 88 204 312 77
Water atoms 452 449 147 155 299
Sructural sulfate 20 45 55 80 N/A
RMS deviations
Bond lengths (A˚) 0.012 0.012 0.010 0.013 0.011
Bond angles () 1.324 1.343 1.420 1.604 1.429
Average B (A˚2) 36.3 28.6 38.6 44.1 27.8
Main chain 34.7 27.2 38.4 43.8 27.1
Side chain 34.7 28.2 38.7 44.2 27.7
Water molecules 44.1 37.1 38.3 34.9 34.4
Nucleotides 31.4 29.7 45.1 47.0 28.0
Structural sulfate 43.0 51.7 59.0 63.5 N/A
R-Factor  ||Fobs|  |Fcalc||/| Fobs|
we crystallized EHV4-TK in complex with physiological Experimental Procedures). This truncated version,
henceforth referred to as EHV4-TK, consists of 330substrates and analogs. To visualize the three- and four-
phosphate conformations of the active site, the ideal amino acids and has a calculated molecular weight of
36.5 kDa. Two different orthorhombic crystal forms werecomplexes of the enzymes would be of AppNHp (a non-
hydrolyzable ATP analog) with Thy or TMP, respectively. obtained for EHV4-TK—C2221 and P21212—and packing
interactions differed between the two forms. As ex-Numerous attempts to obtain such structures, however,
were not successful. As an alternative, we obtained and pected from analogy to other members of the herpesvi-
rus TKs and of the thymidylate kinase (TMPK) family ofstudied structures of TP4A and TP5A complexes, which
can be viewed as the bisubstrate analogs of TMP-ADP proteins, EHV4-TK is homodimeric, as evidenced from
gel filtration experiments (data not shown) and fromand TMP-ATP, respectively.
analysis of the monomer-monomer interactions in the
crystal structure. Each monomer consists of a five-Results
stranded parallel  sheet core surrounded by five core
	 helices and five peripheral helices (Figure 1A). TheOverall Structure of EHV4-TK
Data collection and refinement statistics are presented dimer interface is roughly triangular in shape; it is cre-
ated by three helices from each monomer (	4, 	7, andin Table 1. EHV4-TK consists of 352 amino acid residues
with a calculated molecular weight of 38.8 kDa. Since 	11) stacking against each other.
Homology to other enzymes, especially to HSV1-TKwe could not obtain reproducible crystals with the full-
length EHV4-TK construct, we produced a variant (Figure 1B), suggests three regions to be of particular
importance for the function of EHV4-TK (Wild et al.,(EHV4-TK-
22N) lacking the first 22 N-terminal residues
that is kinetically similar to the full-length enzyme (see 1997). The first critical region is the phosphate binding
Dual Activity of HSV1-TK and EHV4-TK
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Figure 1. Structure of EHV4-TK
(A) A ribbon diagram of the ADP-Thy complex is shown in stereo, with ball-and-stick portrayals of the substrates. One of the monomers has
the open Lid conformation, the other the closed conformation. Only in the latter is the essential Arg196 at an interacting distance to the ADP
molecule, making the closed Lid conformation the catalytically relevant conformation.
(B) The sequences of EHV4-TK and HSV1-TK exhibit 35% identity; while hTMPK has only 9% sequence identity with EHV4-TK (Brown et al.,
1998), its crystal structure overlaps well with many similar secondary structural elements. The Lid and P loop, essential for catalysis, are
highlighted. All structure figures were made with Bobscript (Esnouf, 1997; Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994). The sequence
alignment of EHV4-TK and HSV1-TK was performed with CLUSTAL W (Thompson et al., 1994), that of EHV4-TK and hTMPK was based on a
structural alignment in O (Jones et al., 1991).
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loop (P loop), comprising the GX4GKS/T motif (residues The TP5A molecule was designed to mimic a four-
phosphate conformation, that is, either the “reactant”32–39 in full-length EHV4-TK). The main chain nitrogen
atoms of Gly35, Gly37, Lys38, and Ser39 hydrogen bond state (ATP-TMP) or the “product” state (ADP-TDP), plus
a linker (Scheme 4). We observe at least two differentto the -phosphate of ADP (or to the corresponding
atoms in the TP4A and TP5A structures). The side chain conformations of the TP5A molecule (not equivalent to
the two possible TP5A configurations shown in Schemeoxygen atom of Thr40 hydrogen bonds to the
	-phosphate. The second conserved region, which con- 4) in monomers A and C, and assigned them equal occu-
pancy in our modeling. The electron density in mono-tains the DRY/H/F motif, is present in EHV4-TK as
D138R139H140. Residue Asp138 is expected to bind to the mers B and D is more difficult to interpret, and we will
not address them here.ATP/ADP via a magnesium ion, which is absent in our
structures. Arg139 appears to be vital to catalysis, as
its guanidinium moiety binds to an oxygen atom of the
transferred phosphate group. The third conserved re-
gion, known as the Lid, is a flexible loop comprising
residues 192–205 that can close over an occupied active
site. In this way, one of the Lid arginine residues (Arg196)
comes into close proximity to the phosphate groups.
Scheme 4. Two Possible Conformations for the TP5A Molecule:
ATP-Linker-TMP, ADP-Linker-TDPComplexes Examined
The ADP-Thy and SO4-Thy Structures
The main conformation of TP5A in monomer C is shownThe ADP-Thy structure represents a “dead end” com-
in Figure 2B and the two conformations in simulatedplex in which the active site holds one product (ADP)
annealing omit density are shown in Figure 3B. In all ofand one reactant (Thy). Despite its mixed character, this
the monomers in the TP5A complex the Lids are in ancomplex allows the observation of the nucleophilic 5-
open conformation. Modeling a closed Lid conformationThy-hydroxyl and the two phosphates of ADP. Compar-
reveals a steric clash between the -phosphate (relativeing the SO4-Thy complex to the isomorphous ADP-Thy
to the adenine base) and the closed Lid (Figure 2B).complex reveals that the sulfate ion occupies the
Since the -phosphate is the only phosphate group in-phosphate site. The asymmetric unit of each crystal
TP5A that makes no protein interactions, we concludestructure comprises a dimer whose monomers are de-
that it functions as the linker phosphate. Therefore, innoted A and B. For insight into the dual activity of EHV4-
contrast to the TP4A complex, the TP5A complex mimicsTK, we must compare these structures to those that
the “reactant” state: ATP-linker-TMP. In summary, TP5Amodel the three- and four-phosphate configurations.
mimics ATP  TMP, but not ADP  TDP, and TP4AThe EHV4-TK TP4A and TP5A Structures
mimics ADP  TMP, but not ATPThy.These structures adopt the same space group and most
HSV1-TK in Complex with TP5Aof their general features are identical. Each asymmetric
Here the asymmetric unit is a dimer and we have de-unit comprises two dimers whose monomers are de-
noted its monomers as A and B. Surprisingly, the twonoted A, B, C, and D. Figure 2 illustrates the binding
monomers in this complex bind to different substrates—regions of these complexes. The TP4A complex is ex-
one to TP5A and the other to thymidine and a sulfatepected to mimic a three-phosphate conformation, either
ion. We attribute the presence of thymidine to residualthe “reactant” state (ATP-Thy) or the “product” state
quantities of the nucleoside remaining following purifi-(ADP-TMP), plus a linker (Scheme 3).
cation. Analysis of crystal contacts reveals that the pres-
ence of a TP5A molecule in monomer B is not compatible
with the crystal packing. Thus, only a dimer of mixed
nature (i.e., TP5A in one monomer, Thy in the other)
can incorporate into the growing crystal. A schematic
diagram of the interactions made by TP5A in this com-
plex is presented in Figure 2C and a simulated annealing
omit map of the inhibitor in Figure 3C. Again the -
Scheme 3. Two Possible Configurations for the TP4A Molecule: phosphate seems to be the linker—it makes no hydro-
ADP-Linker-TMP and ATP-Linker-Thy gen bonds to the binding pocket and only one to the
closed Lid. As in the EHV4-TK-Thy-SO4 structure, theAn examination of the binding pocket of this complex
sulfate group bound to the second monomer of HSV1-led us to conclude that our EHV4-TK-TP4A structure is
TK sits in the position normally occupied by thea mimic of an ADP-TMP state. This conclusion is derived
-phosphate group. An overlay of monomers of EHV4-from the observation that the -phosphate makes no
TK and HSV1-TK is shown in Figure 4A.hydrogen bonds to the surrounding protein (Figure 2A).
Furthermore, the -phosphate would, in a closed Lid
(i.e., catalytically active state) conformation, displace The Conformations of the Lid Region
The Lid region, a conserved motif among nucleosideArg196 (see Lid discussion below). These facts suggest
that the -phosphate functions as a linker between an and nucleoside monophosphate kinases, is usually highly
flexible and alters its conformation from an open state inADP moiety and a TMP moiety and that the TP4A com-
plex is a mimic of the product state. A simulated anneal- the absence of substrate in the ATP site, to a closed state
upon ATP binding (Ostermann et al., 2000; Sekulic eting omit map of TP4A is shown in Figure 3A.
Dual Activity of HSV1-TK and EHV4-TK
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Figure 2. Schematic Diagram Showing the
Interactions Made by TP4A and TP5A
Due to the all-open Lid conformations in the
EHV4-TK TP4A and TP5A complex structures
(but closed in the HSV1-TK structure), in (A)
and (B) we modeled the closed-Lid conforma-
tion as observed in the EHV4-TK/ADP-Thy
complex (simulated contacts shown in red
and marked with an asterisk).
(A) EHV4-TK complexed with TP4A. Owing to
the 0.4 A˚ displacement of the -phosphate,
there is only one hydrogen bond to the P loop.
(B) EHV4-TK complexed with TP5A, where
only the mechanistically relevant conforma-
tion is shown.
(C) HSV1-TK complexed with TP5A.
al., 2002; Vonrhein et al., 1995). In most of these kinases, the TP4A and TP5A structures, the Lid regions of all
four monomers in the asymmetric unit are in the openmammalian thymidylate kinases being a notable excep-
tion, this conformational change brings one or more conformation. The conformations are summarized in Ta-
ble 2.arginine residues into the close proximity of the sub-
strate phosphates, enabling the arginine to play a direct Examination of the crystal packing in the ADP-Thy
and SO4-Thy structures suggests that the open Lid con-role in catalysis. Since in all of our EHV4-TK structures
the ATP site is occupied we expected to observe only formation in these complexes could be a crystallization
artifact, due to the interaction of two residues at thethe closed Lid conformation. However, in the ADP-Thy
and SO4-Thy structures, only one of the two monomers edges of the Lid, Arg194 and Ile203, with symmetry-
related Gly128 and Arg127, respectively. Overlaying thein the asymmetric unit is in the closed conformation,
the other being in the open conformation. Moreover, in closed-Lid conformation from ADP-Thy or SO4-Thy
Structure
1270
Dual Activity of HSV1-TK and EHV4-TK
1271
Figure 4. Comparison of EHV4-TK to HSV1-TK
(A) The structures of EHV4-TK (cyan) and
HSV1-TK (Wild et al., 1997) (red) overlay well
with a RMSD of 1.45 A˚ over 269 compared
atoms.
(B) While the P loops and ligands of the EHV4-
TK-ADP-Thy (cyan) HSV1-TK-ADP-Thy (red)
overlap smoothly, the Lid regions follow dif-
ferent paths. This puts the putative conforma-
tion of EHV4-TK’s Arg198 at a position that
does not allow it to interact with the ADP
molecule, in contrast to the homologous
Arg222 of HSV1-TK. The dashed bonds for
EHV4-TK-Arg198 signify that the residue is
modeled as its most probable rotamer, but
not refined owing to ambiguous electron
density.
(C) The closed-Lid state HSV1-TK-Thy-ADP
(red) and EHV4-TK-Thy-ADP (cyan) con-
trasted with one another and with open-Lid
EHV4-TK-ADP-Thy (blue). The closed Lid
state of EHV4-TK prevents Tyr78 from inter-
acting with the thymidine molecule, while in
HSV1-TK this interaction is maintained in the
closed Lid state.
structures on the open-Lid TP4A and TP5A complex cally clash with the side chain of Arg196 of the Lid region.
Least-squares alignment of the two monomers in thestructures reveal that in this case it is not symmetry
related molecules that prevent Lid closure, but rather ADP-Thy or SO4-Thy structures demonstrates that vary-
ing the conformation of the Lid region in these com-that the linker phosphate in these analogs would steri-
Figure 3. Omit Density of Inhibitors
After refinement was completed, the bound inhibitor models were omitted for a refinement cycle to eliminate model bias. The 2.5 sigma
difference density from this cycle (Fo  Fc) is shown superimposed on the final, refined inhibitor models.
(A) EHV4-TK-TP4A, monomer A.
(B) EHV4-TK-TP5A, monomer C. In this complex we observed electron density not accountable by a single conformation for the phosphate
groups; the mechanistically relevant conformation is shown with yellow bonds.
(C) HSV1-TK-TP5A, monomer A.
Structure
1272
Table 2. The Lid Regions of All Four Monomers
Complex Monomer A Monomer B Monomer C Monomer D
EHV4-TK Thy-ADP open closed
EHV4-TK Thy-SO4 open closed
EHV4-TK-TP4A open open open open
EHV4-TK-TP5A open open open open
HSV1-TK-TP5A closed closed
plexes does not change the positions of the substrates, ity of Glu60 and the phosphate groups in TP4A and TP5A
suggest that the side chain is protonated. This is consis-so the predominantly open Lid conformations we ob-
serve do not affect our structural interpretation. Also, tent with its role as a base in the Thy → TMP reaction
accepting the O5 proton, and as an acid in the reversewhile the open Lid conformation might reflect a state in
which the ATP site is not occupied, it is the closed Lid reaction. In all of the monomers of our TP5A structure,
the thymidine’s deoxyribose and the -phosphate (butconformation that more correctly reflects the presence
of ADP or sulfate in the ATP site. Though the main chain not the thymine base itself) are translated by 0.8–1.0 A˚
relative to those in the ADP-Thy, SO4-Thy, and TP4Aatoms and most of the C carbons of the Lid region are
clearly defined by electron density in the simulated- structures.
A notable difference between HSV1-TK and EHV4-TKannealing omit maps, the electron density is not clear
enough to position the entirety of all of the side chains in the Thy/TMP/TDP binding site lies in the position
of a conserved tyrosine residue. Homologous tyrosinein either the open or the closed Lids.
In contrast to the all-open Lid conformation in the residues in other deoxynucleoside kinases have been
implicated with the kinases’ ability to partially discrimi-EHV4-TK/TP4A and TP5A complex structures, the Lids
of both monomers in the HSV1-TK/TP5A structure adopt nate between ribo- and deoxyribo-substrates (Johans-
son et al., 2001). In EHV4-TK’s open-Lid state, Tyr78the closed conformation and are similar to the Lid re-
gions previously reported in HSV1-TK structures (Ben- occupies a very similar position to the HSV1-TK’s
Tyr101. In EHV4-TK’s closed-Lid state, however, Tyr78nett et al., 1999; Champness et al., 1998; Prota et al.,
2000; Vogt et al., 2000; Wild et al., 1997). The superim- is in a displaced conformation (Figure 4C). The closed-
Lid state of EHV4-TK, which we interpret as the catalyti-posed structures of the Lid regions for the two enzymes
are shown in Figure 4B. The different trace adopted cally relevant state, is not compatible with the tyrosine
side chain pointing toward the nucleoside, and the tyro-by the Lid sequence of HSV1-TK makes its closed Lid
conformation compatible with the presence of the linker sine must rotate away as the Lid closes. This would
suggest that EHV4-TK would be less able than HSV1-phosphate, while a steric clash would result from a
closed Lid conformation in the EHV4-TK/TP5A complex. TK to discriminate between ribo- and deoxyribonucleo-
sides. Surprisingly, this difference between the tyrosineIn HSV1-TK, Lid arginines Arg220 and Arg222 point to-
ward the substrates. In the EHV4-TK/SO4-Thy complex side chain conformation of HSV1-TK and EHV4-TK does
not affect the relative rates of ribonucleoside phosphor-(and, to the extent to which we can visualize its electron
density, in the EHV4-TK/ADP-Thy complex), one of ylation by the two enzymes: Urd and Cyd are phosphory-
lated by both enzymes, though not as well as dUrd andthese conserved arginine residues, Arg196, has strong
electron density that shows it to be in a position enabling dCyd (data not shown).
interaction with the -phosphate of ATP/ADP when in
the closed conformation (Figure 4B). While we cannot The ATP/ADP Binding Site
model the tip of the side chain of EHV4-TK’s other con- ADP binds to EHV4-TK mainly through hydrogen bonds,
served arginine, Arg198, with confidence, it seems to but also via -overlap with Arg192. The -phosphate
be pointing away from the active site. This calls into occupies the cavity that is formed by the P loop. In the
question its role in catalysis. sulfate derivative structure presented here, the sulfate
occupies this -phosphate position. TP4A, a bisubstrate
analog, shows an anomaly in the binding of itsThe Thy/TMP/TDP Binding Site
-phosphate, which is displaced from the P loop byThe Thy binding region of EHV4-TK is shown schemati-
0.4 A˚. This may be the result of constraints in thecally in Figure 2. A conserved glutamine residue, Gln102,
conformation of the TP4A molecule that do not occurpositions the phosphoryl-accepting substrate via two
with separate substrates. In the closed Lid ADP-Thyside-by-side hydrogen bonds. The thymine base makes
structure, Arg196 from the Lid region makes hydrogenstacking interactions with nearby aromatic rings, Phe105
bonds to the -phosphate; this doesn’t occur in theand Phe148. In the more relevant closed-Lid conformation,
TP4A and TP5A structures, in which all the Lids are open.the O3 atom of the Thy deoxyribose binds to the con-
The HSV1-TK ATP/ADP binding site has been describedserved glutamic acid residue Glu201. The sugar O5
earlier (Wild et al., 1997).atom in the ADP-Thy complex, the -phosphate in the
TP4A complex, and the -phosphate in the TP5A complex
interact with the conserved Glu60. As a consequence Comparing and Contrasting EHV4-TK and HSV1-TK
Although the overall sequence identity is just 36%, theof the bulkier phosphate group in TP4A and TP5A, this
residue sits lower in the binding pocket than it does in crystal structures of EHV4-TK and HSV1-TK overlap very
well (Figure 4A). The most visible difference is the differ-the ADP-Thy and SO4-Thy structures. The close proxim-
Dual Activity of HSV1-TK and EHV4-TK
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ent position and sequence of helix 	10 in the EHV4-TK in a unique position to do this by comparing the crystal
structures of EHV4-TK in complex with TP4A or TP5A,and HSV1-TK structures. Also, translations of helices
	3, 	4, 	8, and 	12 are evident. The binding pockets, and the structures of HSV1-TK in complex with TP5A
and TMP-ADP (Wild et al., 1997). Earlier analyses of thehowever, have much in common. Both enzymes depend
on a glutamine residue (Gln102 in EHV4-TK, Gln125 in dual activity of HSV1-TK were based only on two- and
three-phosphate conformations, and did not include aHSV1-TK) to position the phosphoryl-accepting sub-
strate via two side-by-side hydrogen bonds. The O5 of four-phosphate complex. As such, they are incomplete.
As described in the results section, we used TP4A andthe deoxyribose, the site of phosphorylation in the Thy→
TMP reaction, binds to a conserved glutamic acid resi- TP5A as bisubstrate analogs. In each complex structure,
one phosphate group made no interaction with the en-due in both structures (Glu60 in EHV4-TK and Glu83 in
HSV1-TK). The P loops align very well (Figure 4B): the zyme. Further, that same phosphate group was in a
position incompatible with phosphoryl-group transfer.distances between the C	 atoms range from 0.1 to 0.7 A˚.
The most obvious difference in the nucleoside binding This phosphate was dubbed the “linker” phosphate, and
we concluded that our complexes mimicked the ADP-pockets of HSV1-TK and EHV4-TK is at the thymine
binding site, specifically the presence of Phe105 in TMP and ATP-TMP states.
So how do herpesvirus TKs accommodate both ADP-EHV4-TK where the analogous residue in HSV1-TK is
Met128. Pilger and coworkers (Pilger et al., 1999) cre- TMP and ATP-TMP in the active site? The difference in
linear size between a Michaelis complex of ADP-TMPated a Met128Phe mutation of HSV1-TK that not only
lost the ability to phosphorylate antiherpetic prodrugs, and that of ATP-TMP is2.5 A˚. Comparison of the EHV4-
TK structure with TP5A to that with TP4A, and the HSV1-but also lost its natural thymidine kinase function. Mod-
eling this mutation in the binding pocket of HSV1-TK TK structure with TP5A to that with ADP-TMP (Wild et
al., 1997), reveals that the mechanisms of the accommo-(data not shown) reveals that the likely reason that this
mutation failed to improve phosphorylation was steric dation differ. As predicted by Wild et al., the TMP phos-
phate is displaced in HSV1-TK (Wild et al., 1997). Forinterference between the introduced phenyl group and
Ile100. While the corresponding residue in EHV4-TK is EHV4-TK, the answer lies not in one, but rather in several
substrate conformational changes that compensate foralso an isoleucine (Ile77), it does not interfere with
Phe105 because the C	 traces of EHV4-TK and HSV1- the increased size of ATP over ADP (or TDP over TMP).
Figure 5 shows superimposed views of three- and four-TK differ by 1.3 A˚ here, a distance ensuring that there
is enough room for the phenyl group and the isoleucine. phosphate configurations of HSV1-TK and EHV4-TK.
Notably, the position of the thymine base is un-We predicted that the double mutant of HSV1-TK with
Met128Phe and Ile100Ala, to make more room for the changed between the different structures of HSV1-TK
and EHV4-TK. The most noticeable change is in thephenyl side chain, would display enhanced phosphory-
lation activity toward most substrates. Preliminary ki- position of the phosphate group closest to the thymi-
dine. In HSV1-TK, this phosphate shifts by 2.3 A˚netic results indicate that while the kcat for GCV does
indeed increase by a factor of 2 with respect to the wild- (slightly greater than the 1.5–2 A˚ shift predicted by Wild
et al.) between the ADP-TMP and the ATP-TMP (i.e.,type, the KM increases by a factor of 14 (HSV1-TK WT-
GCV kcat 0.17 s1, KM  56.4 M; HSV1-TK-I100A/ TP5A) complexes, while the adenine-to-thymine dis-
tance (measured between N9 of adenine and N1 of thy-M128F-GCV kcat0.36 s1, KM  796 M). We are cur-
rently using our EHV4-TK structure to design additional mine) remains virtually unchanged (17.4 A˚ versus 17.7 A˚).
Thus, in HSV1-TK the extra bulk of the four-phosphatemutations in HSV1-TK to understand what factors deter-
mine the lower KM observed with the equine herpes configuration is almost completely accommodated by
this rotation of the phosphate group. While such a rota-enzyme.
tion is also observed for the EHV4-TK, it is only 1.2 A˚
in magnitude (comparing the complex that mimics the
Discussion ATP-TMP state (i.e., TP5A) to the ADP-TMP state (i.e.,
TP4A). The remaining bulk of the additional phosphate
Structural Basis for the Dual Activity is accommodated by a shift of the adenosine moiety.
of Herpesvirus TKs In the ADP-TMP complex, the adenine-to-thymine dis-
A remarkable and unique property of herpes thymidine tance is 0.9 A˚ shorter than in the ATP-TMP complex
kinases is their ability to act as both thymidine kinases (16.8 A˚ versus 17.7 A˚). Since ATP is bound by the P
(TKs) and thymidylate kinases (TMPKs). Herpesvirus loop, we looked for a concomitant P loop shift with the
TKs have an evolutionary relationship with TMPKs, as ATP’s phosphates, but such a shift was not detected
seen from sequence similarity (Figure 1B), especially the at the resolution of our structures. This implies that to
DRY/H/F motif, and structural similarities (1.6 A˚ RMSD some extent, in EHV4-TK the ATP has flexibility in its
over 135 atoms used for overlay); it is likely that the position relative to its binding loop. The consequences
TMPK activity of the herpesvirus TKs reflects this rela- of this flexibility present a topic for future study.
tionship. Many of the secondary structural elements are As discussed above, the single most dramatic sub-
present in both kinases. Despite these similarities, strate conformational change between the state with
TMPKs possess high substrate specificity and are totally TMP bound as a product and that with TMP bound as
devoid of any thymidine kinase activity. The focus of the a reactant is the position of the TMP’s phosphate group.
work presented here is to probe the structural features A comparison of herpesvirus TKs to the structurally simi-
present in herpesvirus TKs that are responsible for the lar TMPKs can explain the flexibility of this phosphate
group to occupy different positions. In TMPKs, the TMPdual-phosphorylation activity of these kinases. We are
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Figure 5. Structures of the Active Sites
(A) The structures of the active site of HSV1-TK complexed with TMP and ADP (Wild et al., 1997) (cyan) and with TP5A (red), compared with
(B) the active site of EHV4-TK complexed with TP4A (cyan) and TP5A (red) show that a phosphate group must move for a thymidylate kinase
reaction to occur. In HSV1-TK, the TMP phosphate group (arrow 1) is offset 2.3 A˚, while the adenine (arrow 2) and thymine (arrow 3) bases
superimpose very well. In EHV4-TK, the phosphate motion is less dramatic (arrow 4), and additional conformational changes also take place,
including movement of the adenine bases (arrow 5), but not of the thymine base (arrow 6).
phosphate group is sandwiched between two arginine this region. We propose that this difference in phosphate
binding permits the added flexibility needed in herpesvi-residues, namely Arg45 and Arg97 in the human TMPK.
In contrast, in herpesvirus TKs only a single arginine rus TKs to catalyze both TMP and Thy phosphorylation.
interacts with this phosphate group—Arg139 in EHV4-
TK, Arg163 in HSV1-TK (corresponding to Arg97 in Reasons for EHV4-TK’s Superior GCV
Phosphorylating ActivityTMPK). The remaining position is occupied by a methio-
nine residue (EHV4-TK Met62 and HSV1-TK Met85) in- Given the differences between thymidine and gan-
ciclovir and the fact that neither HSV1-TK nor EHV4-TKstead of an arginine and the C	 traces differ by 3.5 A˚ in
Dual Activity of HSV1-TK and EHV4-TK
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can phosphorylate deoxyguanosine (dG), it is remark- mimic EHV4-TK, taking into consideration the concomi-
tant requirement to modify Ile100 to a smaller residue.able that these TKs can in fact phosphorylate the ribose-
modified guanosine analogs GCV and acyclovir (ACV). As expected, the Met128Phe-Ile100Ala HSV1-TK double
mutant is active and is in fact faster with GCV than wild-Clashes are apparent when a model of a dG molecule
is positioned in the binding pocket of EHV4-TK. We type enzyme, albeit at a cost of a higher KM. In HSV1-
TK-bearing murine and human cells, the IC50 (the GCVchose a standard trans configuration of the dG molecule,
and aligned the deoxyribose moiety of the dG model concentration at which 50% inhibition of cell prolifera-
tion is observed in comparison to parental cells) forwith the deoxyribose group of a Thy molecule, so that
the O5 oxygen would be in a suitable position for reac- GCV is 0.2 M (Loubiere et al., 1999), and therapeutic
plasma concentrations of GCV are usually less than 10tion. In this conformation, though, the guanine base
would clash with Gln125. It is the rigidity of dG’s deoxyri- M. As these concentrations are well below KM for both
the wild-type and the double mutant and thus in thebose group that prevents it from adopting a productive
binding mode in the active site. pseudo-linear portion of the Michaelis-Menten plot, cells
expressing the HSV1-TK(I100A/M128F) mutant would beIn GCV, the flexibility of the disrupted ribose group
allows the guanine base more freedom of position rela- expected to display a higher IC50 (and thus less cell killing
at a given dosage) than the wild-type HSV1-TK. Thetive to the atoms involved in binding. In order to fit into
HSV1-TK’s binding pocket, the guanine base of GCV mutant is therefore unlikely to be an improvement over
wild-type HSV1-TK for suicide gene therapy applica-must adopt an angled conformation relative to a thymine
base (Brown et al., 1995). The side-by-side hydrogen tions. We are currently testing by mutagenesis the role
of the “nucleoside sandwich” in EHV4-TK.bonds at Gln125 are present in the GCV structure, but
offset, with the glutamine side chain rotated to permit The phosphorylation of GCV-MP to GCV-diphosphate
(GCV-DP) is catalyzed by guanylate kinase and not byits OE1 side chain atom to hydrogen bond to two of the
guanine’s acidic N atoms (see Scheme 5 below). Other the viral TKs. In contrast, TMP is efficiently converted
to TDP by viral TKs. Analysis of our EHV4-TK-GCV modelinteractions (not shown in Scheme 5) contribute to bind-
ing as well. The guanine’s carbonyl makes a hydrogen shows no obvious steric interactions prohibiting the
phosphorylation of GCV-MP to GCV-DP. We attributebond to Arg176. The O3-equivalent atom of the modi-
fied ribose moiety is able to hydrogen bond to Tyr101, the lack of such activity to the flexibility of the disrupted-
ribose group.His58, and Glu225. The O5-equivalent atom makes hy-
drogen bonds to Arg163 (in the DRY/F/H motif) and
Arg222 (in the Lid region). Conclusions
The three-dimensional structures of EHV4-TK in com-
plex with TP4A and TP5A reveal the features that enable
it to phosphorylate Thy → TMP and TMP → TDP. Viral
TKs are more flexible in their phosphate binding modes
than TMPK. A combination of a rotation of the TMP
phosphate group and a shift of the adenine base makes
room for the bulkier substrate in the second phosphory-
lation reaction in the binding pocket. In HSV1-TK a larger
rotation of the TMP phosphate is observed without a
Scheme 5. GCV Binding to HSV1-TK concomitant adenine base shift. A key difference be-
tween EHV4-TK and HSV1-TK is the presence of a “nu-
Although we have no structure of EHV4-TK with bound cleoside sandwich” only in the former. This can explain
GCV, we were able to model a GCV molecule into the the higher GCV phosphorylation rate of EHV4-TK vis-a`-
binding site and attempted to rationalize why its activa- vis HSV1-TK. This information has been used to gener-
tion by EHV4-TK might be faster than that by HSV1- ate an HSV1-TK mutant with improved turnover rate with
TK (Loubiere et al., 1999). By analogy with the binding GCV. Further modifications to this mutant that result in
pocket of HSV1-TK, we would expect hydrogen bonds a lower KM will make it an attractive option for suicide
between Glu201 and the O3-equivalent atom as well gene therapy applications.
as paired hydrogen bonds between the guanine base
and Gln102. Important interactions seen in HSV1-TK that Experimental Procedures
cannot happen in EHV4-TK include Tyr101 (the analo-
gous Tyr78 points away from the binding pocket in Protein Expression and Purification
The cloning of EHV4-TK and EHV4-TK-
22N is described elsewhereclosed-Lid conformations of EHV4-TK) and His58 to the
(C.M. et al., unpublished data). We chose to use the 
22N truncationO3-equivalent atom. Further, EHV4-TK could make ad-
to improve crystal growth. In HSV1-TK structures, the first 34 resi-ditional interactions via Glu60 to the O5-equivalent
dues are sensitive to thrombin cleavage and electron density for
atom, which does not occur in HSV1-TK despite the residues 35–45 were missing. We thus chose a construct of EHV4-
analogous Glu83. However, the most prominent differ- TK that would omit analogous residues. The truncated segment is
not required for catalysis, as verified by kinetic assay. The EHV4-ence lies in the “nucleoside sandwich” formed by resi-
TK-
22N enzyme was expressed as a fusion protein (MBP-His6-TK).dues Phe105 and Phe148 of EHV4-TK. Such a sandwich
The protein was expressed in E. coli BL21 C41 (DE3) for 24 hr atinteraction is not possible in HSV1-TK due to the equiva-
18C after induction (at an OD600 of 0.8) with 1 mM IPTG in 2YTlent residue to EHV4-TK-Phe105 being a methionine
medium.
(Met128). To test the hypothesis that this “sandwich For purification, the cells were centrifuged at 4000  g for 30 min,
interaction” makes EHV4-TK superior to HSV1-TK for collected as pellet, resuspended in a wash buffer (50 mM Tris-HCl
[pH 7.5], 100 mM KCl), then recentrifuged. Cells were lysed by aGCV phosphorylation, we mutated HSV1-TK so as to
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